We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

33 hedge funds and large institutions have $17.7M invested in VolitionRx Ltd in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

14% more funds holding

Funds holding: 29 → 33 (+4)

0.05% more ownership

Funds ownership: 1.16% → 1.21% (+0.05%)

3% less capital invested

Capital invested by funds: $18.2M → $17.7M (-$498K)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
13
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$590K
2
LIM
Lagoda Investment Management
New York
+$520K
3
Citadel Advisors
Citadel Advisors
Florida
+$90.4K
4
State Street
State Street
Massachusetts
+$80.5K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$75.4K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$63K
2
Squarepoint
Squarepoint
New York
-$44.2K
3
William Blair & Company
William Blair & Company
Illinois
-$30.4K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$12.7K
5
CPIG
Chicago Partners Investment Group
Illinois
-$1.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$8.48M +$520K +39,100 +7%
AC
2
Armistice Capital
New York
$6.37M +$590K +44,367 +10%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.04M -$63K -4,735 -6%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$596K +$75.4K +5,664 +15%
BlackRock
5
BlackRock
New York
$302K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$224K +$90.4K +6,789 +70%
State Street
7
State Street
Massachusetts
$182K +$80.5K +6,050 +82%
SBCM
8
Silverberg Bernstein Capital Management
New York
$157K +$20.8K +1,565 +16%
Northern Trust
9
Northern Trust
Illinois
$131K +$49.9K +3,749 +64%
Renaissance Technologies
10
Renaissance Technologies
New York
$52.9K +$38.3K +2,875 +280%
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$46.5K – – –
VF
12
Virtu Financial
New York
$28K +$27.1K +2,037 New
XT
13
XTX Topco
Cayman Islands
$24.2K +$23.7K +1,784 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$20.8K – – –
Millennium Management
15
Millennium Management
New York
$19.9K +$19.5K +1,468 New
Cetera Investment Advisers
16
Cetera Investment Advisers
Illinois
$13.6K +$13.3K +1,003 New
HF
17
HRT Financial
New York
$11K +$3.03K +228 +38%
UBS Group
18
UBS Group
Switzerland
$10.1K +$8.94K +672 +974%
CPIG
19
Chicago Partners Investment Group
Illinois
$6.87K -$1.04K -78 -9%
Creative Planning
20
Creative Planning
Kansas
$6.83K – – –
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$4K +$2.4K +180 +120%
TRCT
22
Tower Research Capital (TRC)
New York
$2.99K -$586 -44 -17%
AAS
23
Ameritas Advisory Services
Nebraska
$2.71K – – –
FCMT
24
Founders Capital Management (Texas)
Texas
$1.36K – – –
Bank of America
25
Bank of America
North Carolina
$650 +$27 +2 +4%
1
2

VNRX Hedge Fund Activity: Q3 2025 in Review

33 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2025, worth a combined $17.7M — down 2.7% from $18.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VNRX positions and 3 closed out — a net gain of 4 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was Armistice Capital, adding an estimated $590K. The largest seller was Vanguard Group, cutting an estimated $63K.

  • 33 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2025, up from 29 in Q2 2025.
  • Funds reported $17.7M of VolitionRx Ltd stock for Q3 2025, down 2.7% quarter-over-quarter.
  • 7 funds opened new VolitionRx Ltd positions in Q3 2025 and 3 closed out, a net change of +4 holders.
  • The largest VolitionRx Ltd buyer in Q3 2025 was Armistice Capital, an estimated $590K added.
  • The largest VolitionRx Ltd seller in Q3 2025 was Vanguard Group, an estimated $63K sold.

Based on aggregated 13F filings for Q3 2025.